Vincent J. Burgess Net Worth

The estimated Net Worth of Vincent J Burgess is at least $582 mil dollars as of 29 March 2023. Mr Burgess owns over 4,860 units of Acutus Medical stock worth over $256 and over the last 4 years he sold AFIB stock worth over $0. In addition, he makes $581,268 as Pres y CEO & Director at Acutus Medical.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Burgess AFIB stock SEC Form 4 insiders trading

Mr has made over 1 trades of the Acutus Medical stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 4,860 units of AFIB stock worth $21,578 on 29 March 2023.

The largest trade he's ever made was exercising 4,860 units of Acutus Medical stock on 29 March 2023 worth over $21,578. On average, Mr trades about 486 units every 0 days since 2020. As of 29 March 2023 he still owns at least 7,995 units of Acutus Medical stock.

You can see the complete history of Mr Burgess stock trades at the bottom of the page.

Mr. Vincent J. Burgess biography

Vincent J. Burgess is the Pres, CEO & Director at Acutus Medical.

What is the salary of Mr Burgess?

As the Pres y CEO & Director of Acutus Medical, the total compensation of Mr Burgess at Acutus Medical is $581,268. There are no executives at Acutus Medical getting paid more.

How old is Mr Burgess?

Mr Burgess is 56, he's been the Pres y CEO & Director of Acutus Medical since . There are 5 older and 3 younger executives at Acutus Medical. The oldest executive at Acutus Medical, Inc. is Dr. Graydon E. Beatty, 64, who is the Chief Technology Officer.

What's Mr Burgess's mailing address?

Vincent's mailing address filed with the SEC is C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355.

Insiders trading at Acutus Medical

Over the last 4 years, insiders at Acutus Medical have traded over $34,800 worth of Acutus Medical stock and bought 5,601,584 units worth $87,402,576 . The most active insiders traders include David P Bonita, James E Deerfield Mgmt Iii,... y Shahzad Malik. On average, Acutus Medical executives and independent directors trade stock every 67 days with the average trade being worth of $18,117. The most recent stock trade was executed by R Scott Huennekens on 3 June 2022, trading 60,000 units of AFIB stock currently worth $34,800.

What does Acutus Medical do?

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Complete history of Mr Burgess stock trades at TELA Bio y Acutus Medical

Acutus Medical executives and stock owners

Acutus Medical executives and other stock owners filed with the SEC include:

• Vincent J. Burgess,
  Pres, CEO & Director
• Gary W. Doherty,
  Sr. VP of Fin.
• R. Scott Huennekens CPA, M.B.A.,
  Exec. Chairman
• Steven P. McQuillan,
  Sr. VP of Regulatory & Clinical Affairs
• Charlie Piscitello,
  Chief People Officer
• Tom Sohn,
  Sr. VP, Gen. Counsel & Sec.
• Dr. Derrick Chou Ph.D.,
  Chief Technology Officer
• Dr. Graydon E. Beatty,
  Chief Technology Officer
• Richard M. Kimes,
  Sr. VP of Operations
• David Harrison Roman,
  Sr. VP & CFO
• John F Sheridan,
  Director
• Shahzad Malik,
  Director
• James F. Hinrichs,
  Director
• Tom Sohn,
  SVP, Gen. Counsel & Secretary
• R Scott Huennekens,
  Director
• Kevin Mathews,
  SVP, Commercial
• David Roman,
  President & CEO
• Charlie Piscitello,
  SVP, Chief People Officer
• James E Deerfield Mgmt L.P....,
  
• Gary W. Doherty,
  Chief Financial Officer
• John Barnickel,
  Chief Commercial Officer
• Vincent J Burgess,
  Chief Executive Officer
• David P Bonita,
  Director
• James E Deerfield Mgmt Iii,...,
  
• Advisors Llc Orbi Med Capit...,
  
• James Edeerfield Management...,
  
• Shaden Marzouk,
  Director
• Daniella Cramp,
  Director
• Steven Mc Quillan,
  SVP, Clinical Affairs & QA
• Niamh Louise Pellegrini,
  Director
• Jason K Garland,
  Director
• Takeo Mukai,
  CFO